6th Edition of International Conference on Tissue Engineering and Regenerative Medicine
September 28-30 | London, UK
Disease Modeling and Personalized Regenerative Medicine
Tailored solutions for complex diseases require systems that replicate patient-specific conditions. Disease modeling and personalized regenerative medicine combine 3D tissue models, patient-derived cells, and bioengineered platforms to predict treatment responses and design targeted therapies. By recreating pathological environments in vitro, researchers can evaluate drug efficacy and explore disease progression mechanisms. This approach reduces dependency on animal models and improves translational relevance. Integration with genomic data, artificial intelligence, and bioprinting allows for highly individualized therapeutic planning. Disease modeling and personalized regenerative medicine enhances precision medicine by aligning cellular behavior with specific genetic and environmental factors, making regenerative interventions more effective and patient-centered.
Marco Polettini
DVM, Italy
Sergey Suchkov
N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Alexander Seifalian
Nanotechnology & Regenerative Medicine Commercialisation Centre, United KingdomSubmit your abstract Today
Title :
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title :
Marco Polettini, DVM, Italy
Title :
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Personalized and Precision Medicine PPM as a unique healthcare model via pathology related modeling biodesign inspired translational applications and clinical practice of the next step generation to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation